Stock Events

Stock Events

Sino Biopharmaceutical 

฿4.94
44
+฿0.32+6.93% 09:08 Today

Statistics

Day High
4.94
Day Low
4.7
52W High
5.5
52W Low
3.6
Volume
638,905
Avg. Volume
160,121
Mkt Cap
92.68B
P/E Ratio
7.17
Dividend Yield
2.16%
Dividend
0.11

Upcoming

Dividends

2.16%Dividend Yield
Aug 26
฿0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19AugExpected
Q2 2025
Q4 2025
Q2 2026
0.05
0.34
0.63
0.92
Expected EPS
0.580360176
Actual EPS
0.92035451244

Financials

7.4%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
143.69BRevenue
10.63BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SINOBIO19.BK. It's not an investment recommendation.
Xiaomi
9
1810.HK
Alibaba Group
8
9988.HK
China Construction Bank
6
939.HK
MTR
6
66.HK

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.94B
Zai Lab Limited is involved in the discovery, development, and commercialization of innovative healthcare products, directly competing with Sino Biopharmaceutical's diverse portfolio in the Chinese market.
HUTCHMED (China) Limited
HCM
Mkt Cap2.45B
Hutchison China MediTech Limited, operating in the biopharmaceutical sector, focuses on oncology and immunology, which are also primary areas of focus for Sino Biopharmaceutical, making them direct competitors.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its pharmaceuticals division, competes globally, including in China, in areas such as oncology, where Sino Biopharmaceutical also has significant investments.
Sanofi
SNY
Mkt Cap106.01B
Sanofi operates globally in the pharmaceutical sector, including China, and its activities in areas like immunology and oncology make it a competitor to Sino Biopharmaceutical.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. is a global pharmaceutical corporation with a broad product portfolio that includes treatments in areas where Sino Biopharmaceutical is active, such as oncology, making them competitors.
Novartis
NVS
Mkt Cap304.1B
Novartis AG, a global healthcare company, competes in various therapeutic areas including those that Sino Biopharmaceutical targets, such as oncology and immunology.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. is a global healthcare company that develops pharmaceuticals in key areas like oncology, directly competing with Sino Biopharmaceutical's product range.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC, a global biopharmaceutical company, competes in the development of medicines in oncology, cardiovascular, renal, metabolism, and respiratory diseases, areas that overlap with Sino Biopharmaceutical's interests.

About

SINO BIOPHARM UNSP/ADR
Show more...
CEO
S. Y. Tse
Employees
21435
Country
Cayman Islands
ISIN
TH8483124807

Listings

HK
HK
1177.HK
STU
DE
SMZ1.STU
F
DE
SMZ1.F
MU
DE
SMZ1.MU

0 Comments

Share your thoughts

FAQ

What is Sino Biopharmaceutical stock price today?▼
The current price of SINOBIO19.BK is ฿4.94 THB — it has increased by +6.93% in the past 24 hours. Watch Sino Biopharmaceutical stock price performance more closely on the chart.
What is Sino Biopharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Thailand Exchange exchange Sino Biopharmaceutical stocks are traded under the ticker SINOBIO19.BK.
What is Sino Biopharmaceutical market cap?▼
Today Sino Biopharmaceutical has the market capitalization of 92.68B
When is the next Sino Biopharmaceutical earnings date?▼
Sino Biopharmaceutical is going to release the next earnings report on April 01, 2027.
What were Sino Biopharmaceutical earnings last quarter?▼
SINOBIO19.BK earnings for the last quarter are 0.92 THB per share, whereas the estimation was 0.58 THB resulting in a +58.58% surprise. The estimated earnings for the next quarter are N/A THB per share.
What is Sino Biopharmaceutical revenue for the last year?▼
Sino Biopharmaceutical revenue for the last year amounts to 143.69B THB.
What is Sino Biopharmaceutical net income for the last year?▼
SINOBIO19.BK net income for the last year is 10.63B THB.
Does Sino Biopharmaceutical pay dividends?▼
Yes, SINOBIO19.BK dividends are paid semi-annual. The last dividend per share was 0.04 THB. As of today, Dividend Yield (FWD)% is 2.16%.
How many employees does Sino Biopharmaceutical have?▼
As of September 08, 2026, the company has 21,435 employees.
In which sector is Sino Biopharmaceutical located?▼
Sino Biopharmaceutical operates in the Health & Wellness sector.
When did Sino Biopharmaceutical complete a stock split?▼
The last stock split for Sino Biopharmaceutical was on August 14, 2020 with a ratio of 1.5:1.
Where is Sino Biopharmaceutical headquartered?▼
Sino Biopharmaceutical is headquartered in Hong Kong, Cayman Islands.